Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Cardiovascular Diabetology Année : 2016

Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study

Résumé

To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevated triglycerides and low high-density lipoprotein (HDL) cholesterol, is predictive of risk of silent myocardial ischemia (SMI) or angiographic coronary artery disease (CAD) in asymptomatic patients with type 2 diabetes.
Fichier principal
Vignette du fichier
2016 Valensi et al., Atherogenic dyslipidemia.pdf (27.54 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01818507 , version 1 (29-03-2020)

Licence

Paternité

Identifiants

Citer

Paul Valensi, Antoine Avignon, Ariane Sultan, Bernard Chanu, Minh Tuan Nguyen, et al.. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovascular Diabetology, 2016, 15 (1), pp.104. ⟨10.1186/s12933-016-0415-4⟩. ⟨hal-01818507⟩
74 Consultations
36 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More